In-vitro clonogenicity of mobilized peripheral blood CD34-expressing cells: Inverse correlation to both relative and absolute numbers of CD34-expressing cells

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 234-240

  Serke, Stefan ^a,d   Watts, Mike ^b   Knudsen, Lenen Meldgaard ^c   Kreissig, Carla ^a   Schneider, Ulrike ^a   Schwella, Nimrod ^a   Linch, David ^b   Johnsen, Hans E ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BFU E; CD34+ cells; CFU GM; Clonogenicity

Indexed keywords

CD34 ANTIGEN;

APHERESIS; ARTICLE; BURST FORMING UNIT E; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0029849443     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1918.x     Document Type: Article

References (24)

1. + cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplantation, 13, 479-485.
2. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chauncey, T., Klarnet. J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. & Buckner, C.D. (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Journal of Clinical Oncology, 13, 2547-2555.
3. Bensinger, W.I., Longin, K., Appelbaum, F., Rowlev, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chauncey, T., Storb, R. & Buckner, C.D. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematologly, 87, 825-831.
4. Bezwoda, W.R., Seymour, L. & Dansey, R.D. (1995) High dose chemotherapy with hemopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. Journal of Clinical Oncology, 13, 2483-2489.
5. Brandwein, J.M., Callum, J., Sutcliffe, S.B., Scott, J.G. & Keating, A. (1990) Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplantation, 6, 291-294.
6. Demirer, T. & Bensinger, W.I. (1995) Optimization of peripheral blood stem cell collection, Current Opinion in Haematology, 2, 219-226.
7. Douay, L., Gorin, N.C. & Lemarie, E. (1986) Recovery of CFU-GM in cryopreserved marrow and in vivo evaluation after autologous hone marrow transplantation are predictive of engraftment. Experimental Hematology, 14, 358-365.
8. Fernandez, H.F., Noto. T.A.. Morrell, L., Spector, N., Goodman, M., Smith, R.J., Collier, T. & Cassileth, P.A. (1994) Early engraftment of mobilized autologous peripheral blood progenitor cells (PBPC) collected by large volume leukapheresis (LVL). Blood, 84, (Suppl. 1), 94a (abstract 365).
9. + myeloid progenitors using CD45-RA analysis, Blood, 81, 2301-2309.
10. Fritsch, G., Emminger, W., Buchinger, P., Printz, D. & Gadner, H. (1991) CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Experimental Hematology, 19, 1079-1085.
11. Haas, R., Witt, B., Möhle. R., Goldschmidt, H., Hohaus, S., Fruehauf, S., Wannenmacher, M. & Hunstein, W. (1995) Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor support, Blood, 85, 3754-3761.
12. Johnsen, H.E., for the Nordic Myeloma Study Group Laboratories (1995) Report from a Nordic workshop on CD 34 cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients, Journal of Hematotherapy, 4, 21-28.
13. Kreissig, C. & Serke, S. (1994) Characterization and measurement of CD34-expressing hemopoietic cells. Journal of Hematotherapy, 3, 263-290.
14. Lansdorp, P.M., Sutherland, H.J. & Eaves, C.J. (1990) Selective expression of CD45 isoforms on functional subpopulations of CD34 hemopoietic cells from human bone marrow, Journal of Experimental Medicine, 172, 363-366.
15. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. & Hodson, G.V. (1993) Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341, 1051-1054.
16. Messner, H.A., Curtis, J.E., Minden, M.D., Tritchler, D., Lockwood, G., Takashi, T., Lepinc, J., Jamal, N., Tweedale, M. & Wandl, U. (1987) Clonogenic hemopoietic precursors in bone marrow transplantation. Blood, 70, 1425-1432.
17. Pettengell, R., Morgenstern, G.R., Woll. P.J., Chang, J., Rowlands, M., Young, R., Radford, J.A., Scarffe, J.H., Testa, N.G. & Crowther, D. (1993) Peripheral bood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood, 82, 3770-3777.
18. Serke, S. & Huhn, D. (1990) Effects of various recombinant human hemopoietic growth factors (rhEpo, rhG-CSF, rhGM-CSF, rhll-3) on the growth of peripheral blood progenitor cells (BFU-E, CFUGM). Blut, 61, 25-29.
19. + cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony assay. British Journal of Haematology, 77, 453-459.
20. Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Stern, A.C., Lansdorp, P.M., Bonadonna, G. & Gianni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
21. Spitzer, G., Verma, D.S., Fisher, R., Zander, A., Vellekoop, L., Litam, J., McKredie, K.B. & Dicke, K.A. (1980) The myeloid progenitor cell: its value in predicting hemopoietic recovery after autologous bone marrow transplantation. Blood, 55, 317-323.
22. Sutherland, H.J., Eaves, C.J., Lansdorp, P.M., Philipps, G.I., & Hogge, D.E. (1994) Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood, 83, 3808-3814.
23. Watts, M.J., Sullivan, A.M., Jamieson, E., Pearce, R., Fielding, A., Devereux, S., Goldstone, A.H. & Linch, D.C. (1996) Progenitor cell mobilisation after low dose cyclophosphamide and G-CSF: an analysis of progenitor cell quantity and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. Journal of Clinical Oncology. in press.
24. Weaver, C.H., Birch, R., Schwartenberg, L., West, W. & Hazelton, B. (1994) CD34 content of peripheral blood progenitor cells (PBSC) in the single most powerful predictor of recovery kinetics in patients receiving myeloablative high-dose chemotherapy and PBSC infusion. Blood. 84, (Suppl. 1). 351a (abstract 1388).